Lincocin Soluble Powder, 400 mg/g Powder for Use in Drinking Water for Pigs and Chickens

Medicated drinking water uptake can be affected by the severity of the disease. In
case of insufficient uptake of water, pigs should be treated parenterally.
The susceptibility of Mycoplasma hyopneumoniae to antimicrobial agents is difficult
to test in vitro owing to technical constraints. In addition, there is a lack of clinical
breakpoints for both M. hyopneumoniae and C. perfringens. Where possible, therapy
should be based on local (regional, farm level) epidemiological information
concerning the response of enzootic pneumonia/necrotic enteritis to treatment with
lincomycin.

Special precautions for safe use in the target species:
Use of the veterinary medicinal product preferably should be based on identification
of the target pathogen and susceptibility testing of the bacteria isolated from the
animal. See also the above special warnings for each target species.
Official, national and regional antimicrobial policies should be taken into account
when the veterinary medicinal product is used.
Use of the veterinary medicinal product deviating from the instructions given in the
summary of product characteristics may increase the prevalence of bacteria resistant
to the lincomycin and may decrease the effectiveness of treatment with other
lincosamides, macrolides and streptogramin B due to the potential for cross-
resistance.
Repeated or prolonged use should be avoided by improving the farm management
and hygiene practices.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
This product contains lincomycin and lactose monohydrate, either of which can
cause allergic reactions in some people. People with known hypersensitivity to
lincomycin or any other lincosamide, or to lactose monohydrate, should avoid contact
with the veterinary medicinal product.
Care should be taken not to raise and inhale any dust.
Contact with skin and eyes should be avoided.
Personal protective equipment consisting of approved dust masks (either a
disposable half mask respirator conforming to European Standard EN149 or a non-
disposable respirator conforming to European Standard EN140 with a filter EN143),
gloves and safety glasses should be worn when handling and mixing the product. If
respiratory symptoms develop following exposure, seek medical advice and show
this warning to the physician.

Amended pages: January 2026
In case of accidental exposure to the skin, eyes or mucous membranes, wash the
affected area thoroughly with plenty of water. If symptoms such as skin rash or
persistent eye irritation appear after exposure, seek medical advice immediately and
show the package leaflet or label to the physician.
Wash hands and any exposed skin with soap and water immediately after use.
Do not eat, drink or smoke while handling the product.
Special precautions for the protection of the environment:
Not applicable.